Effects of written informed consent requirements on HIV testing rates: Evidence from a natural experiment

American Journal of Public Health

Volumn 99, Issue 6, 2009, Pages 1087-1092

  Wing, Coady ^a,b,c  

^a SYRACUSE UNIVERSITY   (United States)

^b SYRACUSE UNIVERSITY   (United States)

^c Center for Policy Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; INFORMED CONSENT; LABORATORY TEST; VIRUS LOAD; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COUNSELING; FEMALE; HEALTH CARE POLICY; MALE; MANDATORY PROGRAM; PSYCHOLOGICAL ASPECT; SERODIAGNOSIS; STATISTICAL MODEL; UNITED STATES;

AIDS SERODIAGNOSIS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; COUNSELING; FEMALE; HEALTH POLICY; HUMANS; INFORMED CONSENT; LOGISTIC MODELS; MALE; MANDATORY PROGRAMS; NEW YORK;

EID: 67049155588     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.141069     Document Type: Article

References (14)

1. Branson BM, Hansfield HH, Lampe MAA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17.
2. Roome A, Hadler J, Birkhead G, et al. HIV testing among pregnant women - United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep. 2002;51:1013-1016.
3. Stanley B, Fraser J, Cox NH. Uptake of HIV screening in genitourinary medicine after change to "optout" consent. BMJ. 2003;326:1174.
4. National Alliance of State and Territorial AIDS Directors. Report on findings from an assessment of health department efforts to implement HIV screening in health care settings. Available at: http://www.nastad.org/Docs/ highlight/2007626-NASTAD-Screening-Assessment-Report-062607.pdf. Accessed October 6, 2008.
5. Zetola NM, Klausner JD, Haller B, et al. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA. 2007;297:1061-1062.
6. Goldman J, Kinnear S, Chung J, Rothman DJ. New York City's initiatives on diabetes and HIV/AIDS: implications for patient care, public health, and medical professionalism. Am J Public Health. 2008;98:807-813.
7. Frieden TR. New York City's diabetes reporting system helps patients and physicians. Am J Public Health. 2008;98:1543.
8. Das-Douglas M, Zetola NM, Klausner JD, Colfax JD. Written informed consent and HIV testing rates: the San Francisco experience. Am J Public Health. 2008; 98:1544-1545.
9. Bayer R, Fairchild AL. Changing the paradigm for HIV testing - the end of exceptionalism. N Engl J Med. 2006;355:647-649.
10. Koo DJ, Begier EM, Henn MH, et al. HIV counseling and testing: less targeting, more testing. Am J Public Health. 2006;96:962-974.
11. New York State Department of Health. 2005 guidance for HIV counseling and testing and new laboratory requirements - revised 2006. Available at: http://www.health.state.ny.us/diseases/aids/regulations/2005-guidance/ labreportingrequirements.htm. Accessed October 10, 2008.
12. New York State Department of Health. 2005 guidance for HIV counseling and testing and new laboratory reporting requirements. Available at: http://www.health.state.ny.us/diseases/aids/regulations/2005-guidance/index.htm. Accessed October 10, 2008.
13. Centers for Disease Control and Prevention. BRFSS operational and user's guide. Available at: http://www.cdc.gov/brfss/pubs/index.htm#users. Accessed October 10, 2008.
14. Moulton BR. An illustration of a pitfall in estimating the effects of aggregate variables on micro units. Rev Econ Stat. 1990;72:334-338.